Innate Pharma buy metanicnor
Start price
07.09.14
/
50%
€8.63
Target price
09.03.15
€10.50
Performance (%)
19.99%
End price
09.03.15
€10.35
Summary
This prediction ended on 09.03.15 with a price of €10.35. The prediction had a final performance of 19.99%. metanicnor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innate Pharma | -1.454% | -1.454% | -17.277% | -30.902% |
| iShares Core DAX® | 0.072% | -2.607% | 28.010% | 76.531% |
| iShares Nasdaq 100 | 1.565% | 0.568% | 19.738% | 64.587% |
| iShares Nikkei 225® | 4.291% | 3.504% | 10.820% | 28.960% |
| iShares S&P 500 | 0.976% | 1.850% | 13.245% | 43.074% |
Comments by metanicnor for this prediction
In the thread Innate Pharma diskutieren
IPH Kauf
eines der wenigen Biotech-Unternehmen in der Welt auf der angeborenen Immunität positioniert
das Geld wird es ermöglichen, halten die Ende 2017
(Laufzeit überschritten)